These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
805 related articles for article (PubMed ID: 9222543)
1. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle. Shaw LA; Batey AJ; Coker SJ Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543 [TBL] [Abstract][Full Text] [Related]
2. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood. Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115 [TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo. Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188 [TBL] [Abstract][Full Text] [Related]
4. How can we inhibit 5-HT-induced platelet aggregation and why should we bother? Heptinstall S; Bevan J Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):475-8. PubMed ID: 2465956 [TBL] [Abstract][Full Text] [Related]
5. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588 [TBL] [Abstract][Full Text] [Related]
6. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of U46619 induced human platelet aggregation by aspirin. Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053 [TBL] [Abstract][Full Text] [Related]
8. Platelet antiaggregating activity of ginsenosides isolated from processed ginseng. Lee JG; Lee YY; Kim SY; Pyo JS; Yun-Choi HS; Park JH Pharmazie; 2009 Sep; 64(9):602-4. PubMed ID: 19827304 [TBL] [Abstract][Full Text] [Related]
9. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
10. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619. Pérez-Vizcaíno F; Villamor E; Duarte J; Tamargo J Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910 [TBL] [Abstract][Full Text] [Related]
11. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF. Kawikova I; Arakawa H; Skoogh BE; Löfdahl CG; Lötvall J J Pharmacol Exp Ther; 1996 Jul; 278(1):268-76. PubMed ID: 8764360 [TBL] [Abstract][Full Text] [Related]
13. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome. Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory activity of ginsenosides isolated from processed ginseng on platelet aggregation. Lee JG; Lee YY; Wu B; Kim SY; Lee YJ; Yun-Choi HS; Park JH Pharmazie; 2010 Jul; 65(7):520-2. PubMed ID: 20662322 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
17. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement. Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279 [TBL] [Abstract][Full Text] [Related]
18. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta. Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323 [TBL] [Abstract][Full Text] [Related]
19. Alterations by a thromboxane A2 analog (U46619) of calcium dynamics in isolated rat cardiomyocytes. Hoffmann P; Heinroth-Hoffmann I; Toraason M J Pharmacol Exp Ther; 1993 Jan; 264(1):336-44. PubMed ID: 8423535 [TBL] [Abstract][Full Text] [Related]
20. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]